What Air Liquide does

Air Liquide (EPA: AI) is a publicly traded French industrial gases and services company founded in 1902, headquartered in Paris. The company produces and distributes industrial gases — oxygen, nitrogen, argon, hydrogen, and CO2 — through on-site production plants, extensive pipeline networks (2,223 km in Benelux alone), and merchant distribution channels. Operations span 59 countries with approximately 65,000 employees serving 4.3 million customers and patients, generating approximately €27 billion in 2025 revenue with €3.5 billion net income.

The company operates across four primary segments: Industrial Manufacturing (steel, chemicals, refining, petrochemicals, cement), Electronics/Semiconductors (notably long-term contracts with SK hynix for HBM AI chip production and a Japanese semiconductor manufacturer in Hiroshima), Healthcare (medical gases to 20,000 hospitals and clinics, home healthcare for 2.3 million chronic disease patients, plus Seppic specialty ingredients), and Clean Mobility/Transportation (hydrogen refueling infrastructure including the TEAL Mobility joint venture with TotalEnergies). Air Liquide also operates Seppic for specialty ingredients and ALIAD as its corporate venture capital arm.

The business model centers on long-term take-or-pay contracts of 10-15 years with industrial customers, creating predictable recurring revenue streams. Pricing is not publicly disclosed and is contract-based. Capital intensity is high — €4.2 billion in investment decisions were made in 2025, supporting expansion into renewable hydrogen (Normand'Hy 200 MW, ELYgator 200 MW, Trailblazer 20 MW), carbon capture (Cryocap™ family serving cement, hydrogen, and industrial emissions), and AI-driven operational optimization under the ADVANCE 2025 transformation plan. The company divested its biogas production portfolio to Mobius Renewables in 2026 to focus capital on these higher-growth decarbonization and electronics verticals.

Name

Air Liquide

Legal name

L'AIR LIQUIDE S.A.

Website

https://airliquide.com

Company type

Public

Founded year

1902

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Air Liquide is a Paris-based, publicly traded industrial gases and services company serving manufacturers, healthcare providers, and semiconductor producers across 59 countries through on-site plants, pipeline networks, and long-term take-or-pay contracts.

Ownership category

akta.pro rank

Product category

Industrial Gases and Services

NAICS

Industrial Gas Manufacturing (32512), Industrial Gas Manufacturing (325120)

SIC

Industrial Inorganic Chemicals (2810)

akta.pro primary industry

Air Separation (Oxygen/Nitrogen/Argon) (IMAEACAA)

Keywords

• Industrial gases
• Medical gases
• Air separation
• Carbon capture
• Hydrogen production

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices9 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Infrastructure, Supply Chain, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Industrial Gases Sales: Sale of industrial gases (oxygen, nitrogen, argon, hydrogen, CO₂) through on-site plants, pipeline networks, and merchant distribution. Revenue from long-term contracts with manufacturing customers.
2. Healthcare Services: Medical gases supply to hospitals and healthcare facilities, home healthcare services for chronic conditions (respiratory diseases, diabetes), and specialty ingredients through Seppic subsidiary.
3. Green Bond Financing for Energy Transition Projects: €500 million green bond issuance for low-carbon hydrogen, CO2 capture, and low-carbon air gases projects.
4. Social Impact Programs: Access Oxygen program providing oxygen therapy solutions to underserved healthcare markets, serving vulnerable populations.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels6 records

Core offering

Air Liquide manufactures and distributes industrial and medical gases (oxygen, nitrogen, argon, hydrogen, helium, CO2) through on-site air separation units, pipeline networks, and merchant delivery to industrial manufacturers, healthcare facilities, and semiconductor companies. The company also provides proprietary carbon capture technologies (Cryocap family), large-scale renewable hydrogen production via PEM electrolysis projects (Normand'Hy, ELYgator), home healthcare services for chronic conditions, and specialty ingredients for pharmaceutical and cosmetic markets through its Seppic subsidiary.

Product overview

Air Liquide operates as a world leader in industrial gases, technologies, and services for industry and healthcare. The company offers a comprehensive portfolio spanning core industrial gases (oxygen, nitrogen, helium, argon, hydrogen, CO₂) produced through air separation units, advanced carbon capture technologies (Cryocap™ H₂, Cryocap™ OXY, Cryocap™ FG), and large-scale electrolyzer projects for renewable hydrogen (Normand'Hy, ELYgator, Trailblazer). The healthcare division provides medical gases, home healthcare services for chronic conditions, and specialty ingredients through Seppic. Key technologies include ammonia cracking and autothermal reforming for low-carbon hydrogen production. Major projects include Porthos CO₂ capture infrastructure and TEAL Mobility hydrogen refueling network with TotalEnergies. The company serves over 4 million customers and patients across 59 countries with approximately 65,000 employees.

Differentiator

Problem solved

Functional benefit

Brands

• Cryocap™: Proprietary carbon capture technology using cryogenic process for CO2 capture from industrial emissions
• Cryocap™ H₂
• Cryocap™ OXY
• Cryocap™ FG
• Value-Based Healthcare
• Seppic
• VitalAire
• ALIAD
• Normand'Hy
• ELYgator
• Trailblazer
• Access Oxygen
• TEAL Mobility

Products and services

• Industrial Gases Portfolio (Oxygen, Nitrogen, Argon, Hydrogen, Helium, CO2) Core industrial gas offering of oxygen, nitrogen, helium, argon, hydrogen, and CO2 supplied globally to industrial manufacturers through on-site plants, pipeline networks, and merchant delivery under long-term take-or-pay contracts.
• Medical Gases for Hospitals Pharmaceutical-quality medical gases (oxygen, anesthesia gases, etc.) supplied to operating theatres, intensive care units, emergency rooms, and respiratory wards, with associated services including inventory monitoring and staff training for 20,000 hospitals and clinics worldwide.
• Home Healthcare Services (VitalAire) Home-based healthcare services for chronic conditions including respiratory diseases, diabetes, and Parkinson's disease, providing equipment, therapies, and multidisciplinary care to 2.3 million home patients including the largest contract in Spain serving 90,000 respiratory patients.
• Seppic Specialty Ingredients Specialty ingredients including excipients and active ingredients developed for cosmetics, pharmaceutical, nutrition, and vaccine markets through scientific expertise, marketed under the Seppic brand.
• Cryocap H2 Carbon Capture Solution Proprietary cryogenic technology for capturing CO2 from hydrogen production processes using natural gas, enabling low-carbon hydrogen manufacturing with reduced carbon footprint.
• Cryocap OXY Carbon Capture Solution Carbon capture technology using cryogenic treatment to transform unavoidable industrial emissions into recoverable liquid CO2, enabling emissions reduction for hard-to-abate industrial processes.
• Cryocap FG Carbon Capture Solution for Cement Cryogenic technology specifically designed to capture CO2 from cement industry flue gas, transforming industrial emissions into recoverable liquid CO2 at scale of 3,000 Nm3/h per unit.

Quantifiable outcome

• CO₂ emissions reduction of 13% vs 2020 baseline
• +5 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

Ten partnerships are on record, tiered long-term supply partnership, innovation partnership, major strategic contract, strategic expansion in indian market, flagship joint venture, core technology partnership, hydrogen ecosystem development, major ccs project, ccs infrastructure partner and hydrogen fueling partnership.

• Sillenolong-term supply partnershipStrategic or Co-development Partner · 24 June 2026Air Liquide Karabatan Tech Gases signed long-term agreement to supply nitrogen and dry compressed air to Silleno's polyethylene plant in Kazakhstan's Atyrau region. €70 million investment in two air separation units within National Industrial Petrochemical Technopark.
• Holciminnovation partnershipStrategic or Co-development Partner · 10 June 2026Air Liquide deployed first industrial-scale Cryocap™ FG pilot unit at Holcim's CaptureLab in France specifically designed for cement sector decarbonization. The 3,000 Nm³/h unit tests carbon capture technology under real cement production conditions.
• SK hynixmajor strategic contractStrategic or Co-development Partner · 3 June 2026Air Liquide signed a long-term contract to supply industrial gases to SK hynix's new HBM chip packaging and testing facility (P&T7) in Cheongju, South Korea. Investment of nearly €200 million for dedicated nitrogen production unit.
• NovaAirstrategic expansion in indian marketStrategic or Co-development Partner · 27 October 2025Air Liquide announced intention to acquire India's NovaAir to expand presence in the Indian industrial merchant market. The acquisition aims to strengthen Air Liquide's position in the Indian market and improve service across various industrial sectors.
• TotalEnergiesflagship joint ventureStrategic or Co-development Partner · 18 February 2025Air Liquide and TotalEnergies formed a 50/50 joint venture to develop 380 MW of electrolysis capacity in France and Netherlands, representing over €1 billion investment in green hydrogen production. Also jointly developing over 100 hydrogen refueling stations through TEAL Mobility.
• Siemens Energycore technology partnershipStrategic or Co-development PartnerStrategic partnership with Siemens Energy for PEM electrolyzer technology deployment in Normand'Hy 200 MW project and other large-scale hydrogen production initiatives. Leverages over 60 years of hydrogen expertise combined with Siemens Energy's electrolyzer technology.
• Airbus/Korean Air/Incheon International Airport Corporationhydrogen ecosystem developmentStrategic or Co-development PartnerPartnership to develop hydrogen ecosystem at Incheon Airport in South Korea, including two high-capacity hydrogen fueling stations operational since August 2021, with roadmap for broader hydrogen infrastructure expansion.
• Aalborg Portlandmajor ccs projectStrategic or Co-development PartnerAir Liquide providing Cryocap technology for ACCSION carbon capture project at Aalborg Portland's Rørdal cement facility in Denmark. €2.2 billion government contract for capturing 1.25 million tonnes CO2 annually, with €220 million EU Innovation Fund backing.
• Harbour Energyccs infrastructure partnerStrategic or Co-development PartnerPartnership with Harbour Energy for CO2 transport and storage infrastructure as part of carbon capture and storage projects, including Aalborg Portland ACCSION project.
• Toyota Motor North Americahydrogen fueling partnershipStrategic or Co-development PartnerAir Liquide providing hydrogen fuel supply for Toyota's hydrogen fuel cell-powered Class 8 trucks deployment at North America Parts Center California campus, with fueling operations beginning later this year.

Scale indicators19 records

Recent moves9 records

Expansion highlights6 records

Regional players

• Yingde Gases Group: China's largest independent industrial gas supplier with on-site and merchant offerings. Comparable product set to Air Liquide's industrial gases business but primarily serves Chinese onshore customers.

Direct peers

• Linde plc: Global industrial gas major headquartered in the UK/Ireland with comparable product portfolio (atmospheric gases, hydrogen, helium) and on-site/pipeline delivery model. Closest direct competitor across virtually all of Air Liquide's geographies and end-markets, including electronics and healthcare gases.
• Air Products and Chemicals: US-based industrial gas and hydrogen heavyweight. Direct overlap in merchant gases, on-site supply, and large hydrogen/CCS projects. Competes head-to-head for major semiconductor and industrial contracts and pursues similar blue/green hydrogen strategies.
• Nippon Sanso Holdings (Taiyo Nippon Sanso): Japan-headquartered industrial gas company and the fourth global player. Direct competitor in semiconductor ultra-pure gases, particularly in Japan, South Korea, and Taiwan where it competes with Air Liquide for fab supply contracts.
• Messer Group: Privately-held German industrial gas producer (post-CVC partnership) operating in Europe, Americas, and Asia. Directly comparable merchant and on-site gas offerings; a long-standing competitor especially in Europe and the Americas.
• Iwatani Corporation: Japanese industrial gas and hydrogen player with strong presence in hydrogen liquefaction, transport, and refueling infrastructure. Comparable in hydrogen mobility and electronics gases, particularly within Asia.
• SOL Group: Italian-headquartered industrial and medical gas supplier active across Europe. Direct competitor in industrial merchant gases, home healthcare, and medical gases; comparable European footprint though smaller scale.

Others

• Chart Industries: US cryogenic equipment manufacturer supplying air separation, hydrogen liquefaction, and CO₂ capture hardware. Adjacent rather than directly competitive, but its equipment is used by Air Liquide and other gas majors.
• Linde Engineering (part of Linde plc): Engineering arm of Linde that builds ASUs, hydrogen plants, and CO₂ capture units. Direct competitor in technology licensing and EPC for industrial gas production assets that Air Liquide also designs and builds internally.

Emerging players

• Showa Denko: Japanese chemicals and electronic materials producer with adjacent specialty gas offerings (electronic gases, hydrogen). Partial overlap with Air Liquide's electronics gas segment in Japan and Asia.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/AirLiquideGroup
• LinkedInlinkedin.com/company/airliquide

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries7 records

Funding overview

Funding rounds4 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A47 records

Investments11 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Air Liquide